Assertio Therapeutics, Inc.
Idatha yomhlelo osemthethweni
0abalandeli
2018yasungulwa
Mayelana ne-Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Ikomkhulu251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Kusungulwe2018
IsimoKuyasebenza
Amalungelo obunikaziilungelo lobunikazi elingu-1
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Ukubuyekezwa
Azikho izibuyekezo okwamanje. Usebenze ne-Assertio Therapeutics, Inc.? Yiba owokuqala ukwabelana nolwazi lwakho.
Ulwazi lwezomthetho
| Igama elisemthethweni | Assertio Therapeutics, Inc. |
|---|---|
| I-LEI | 549300L2A9NTF1JVDP20Buka ku-GLEIF ↗ |
| Ikheli elibhalisiwe | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Isimo | Kuyasebenza |
Imithombo: GLEIF · kubuyekeziwe Oct. 16, 2026
Ukuxhumana nezixhumanisi
Indawo
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Le inkampani yakho?
Funa leli khasi mahhala ukuze wengeze ilogo yakho, imikhiqizo, izithombe nemisebenzi, futhi uphendule izibuyekezo.
Funa leli khasiJoyina i-Heelky ukuze uxhume, uqashe futhi ukhule
Dala i-akhawunti yamahhala ukuze uthumele umyalezo kubantu, ufake izicelo zemisebenzi futhi ushicilele imisebenzi.
Joyina manje — kumahhala